查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439436

透析设备 - 全球市场考量、竞争格局、市场预测（2030 年）

Dialysis Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按订单生产 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

预计2023年全球透析设备市场规模将达到744.4亿美元，2030年将达到988.4亿美元，2024-2030年预测期间内复合年增长率为4.84%。 对透析机的需求主要由多种原因推动，包括老年人口的增加（其中衰老是肾功能丧失的主要风险因素）以及糖尿病盛行率的增加（其中高血糖与肾血管损伤有关）。由于肾衰竭患病率的上升，这一数字正在迅速增加。 此外，高血压是与肾衰竭广泛相关的另一个主要因素。 此外，连续肾臟替代疗法（CRRT）的发展等技术进步也是推动2024-2030年预测期内透析机市场成长的主要影响因素。

透析机市场动态

由于多种原因，透析机市场正在蓬勃发展，其中主要原因之一是慢性肾臟病率的上升。 这可能是由于全球糖尿病盛行率不断上升。 根据国际糖尿病联盟在第10版IDF糖尿病图谱中提供的数据，2022年全球20岁至79岁之间有5.37亿人被诊断出患有糖尿病。 同一份文件也预测，到2030年，糖尿病盛行率将增加至6.43亿人。 高血糖会导致糖尿病肾病变的发生，而糖尿病肾病变本身就是慢性肾臟病和末期肾病的重要危险因子。 许多研究已经证实高血糖对肾臟有多因素影响。 例如，高血糖会使供应肾臟的血管变窄，大大影响肾臟的过滤能力。 高血糖与慢性血流动力学和代谢变化有关，而慢性血流动力学和代谢变化又与讯号传导途径、细胞激素、转录因子和其他因素的变化有关。 因此，糖尿病盛行率的上升与糖尿病肾病变和终末期肾病等肾臟疾病相关病例的增加有关，这将推动对透析治疗的需求，并最终在预测期内（2024年）推动透析治疗的需求。2030年）将对透析设备市场产生正面影响。

推动透析设备市场需求的另一个重要面向是老年人口的增加。 根据世界卫生组织（WHO）《健康老化十年（2020-2030）》报告中的数据，60岁及以上人口占总人口的比例将从2019年的10亿增加到2030年的10亿。预计这一数字将增加34%，达到14亿人。 报告进一步预测，到2050年，全球老年人口将达到21亿。 老化与肾功能进行性衰退有关，与老化相关的结构、分子和功能变化会影响肾臟的修復能力，使老年人容易患上各种肾臟疾病。我是。 因此，老年人口的增加将增加肾臟疾病的盛行率并增加透析需求，从而推动未来几年透析设备市场的成长。

然而，在经济成长中，与透析手术相关的併发症以及病患透析服务的高成本可能会限制透析设备市场的成长。

除上述因素外，由于 COVID-19 大流行，透析设备市场的收入略有下降。 儘管透析具有高度紧急、维持生命的性质，但其实施率略有下降，而且世界各地的趋势差异很大。 对于这个特定市场，由于透析治疗具有维持生命的性质，因此与 COVID-19 大流行相关的法规并未影响透析需求。 然而，疫情后的情况为透析设备市场提供了有利的创收机会，因为透析设备市场充分恢復活动，并改善了预测期内透析设备市场的前景。

透析设备市场区隔分析

在透析设备市场的产品领域中，连续性肾臟替代疗法（CRRT）类别预计在预测期内复合年增长率最高。 这是由于这种类型的透析所提供的好处。 CRRT 的主要优点之一是透析速度较慢，与其他透析方法相比，可显着减轻透析过程中心臟的压力。 由于是在 24 小时内进行，而不是 4 小时，因此减轻了心臟的负担。

本报告提供了全球透析设备市场的研究和分析，包括市场规模和预测、促进因素和挑战以及公司和产品概况。

目录

第 1 章透析机市场报告简介

第 2 章透析机市场执行摘要

  • 调查范围
  • 市场概览
  • 竞争评估
  • 财务基准

第 3 章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第 4 章透析设备市场主要因素分析

  • 透析机市场驱动因素
    • 扩大老年人口基础
    • 糖尿病盛行率不断上升
    • 高血压盛行率不断上升
    • 产品开发方面的技术进步
  • 透析设备市场的抑制因素与挑战
    • 与手术相关的併发症
    • 经济成长中病患的透析服务成本高昂
  • 透析机市场机遇
    • 改良产品设计
    • 改善新兴经济体获得透析服务的机会

第 5 章透析机市场波特五力分析

第 6 章COVID-19对透析机市场的影响分析

第 7 章透析设备市场布局

  • 依产品类型
    • 血液透析设备
    • 腹膜透析设备
    • 连续性肾臟替代治疗装置
    • 消耗品
  • 可移动性别
    • 固定型
    • 可移动
  • 按最终用户
    • 医院
    • 透析中心
    • 居家照护环境
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第 8 章透析机市场：全球公司份额分析 - 3 至 5 家主要公司

第 9 章透析设备市场公司及产品概况

  • Fresenius Medical Care
  • B. Braun Melsungen AG
  • Nipro Corporation
  • Dialife SA
  • Baxter
  • Cantel Medical Corporation
  • NIKKISO CO. LTD.
  • Asahi Kasei Medical
  • NxStage Medical, Inc
  • Infomed SA
  • Medtronic
  • Anjue Medical Equipment Co., Ltd
  • Dialco Medical Inc
  • SWS Hemodialysis Care Co., Ltd
  • TORAY MEDICAL CO,.LTD
  • Trivitron Healthcare
  • BLT Biolight Meditech
  • QUANTA Dialysis Technologies

第 10 章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络资讯

Product Code: DIMDCL0242

Dialysis Devices Market By Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines And Consumables), By Mobility (Stationary And Portable), By End User (Hospitals, Dialysis Centers, And Homecare Settings), and by geography is expected to grow at a steady CAGR (forecast period- 2024-2030) owing growing prevalence of kidney failure primarly due to increasing prevalence of diabetes and hypertension

Global dialysis devices market was valued at USD 74.44 billion in 2023, growing at a CAGR of 4.84% during the forecast period from 2024 to 2030 to reach USD 98.84 billion by 2030. The demand for dialysis devices is witnessing a surge majorly due to the rising prevalence of kidney failure due to various reasons such as rising geriatric population wherein age acts as a major risk factor for loss of kidney function, rising prevalence of diabetes in which hyperglycemia is linked with blood vessel damage in kidneys. Furthermore, hypertension is another key factor which is extensively linked with kidney failure. Additionally, the technological advancements such as the development of continuous renal replacement therapy (CRRT) have also been a major influential factor in boosting the growth of the dialysis devices market during the forecast period from 2024-2030.

Dialysis Devices Market Dynamics:

The dialysis devices market is gaining momentum due to a variety of reasons with one of the key reasons being the rising prevalence of chronic kidney disorders. This can be attributed to the rising prevalence of diabetes across the globe. According to the data provided by the International Diabetes Federation in their tenth edition of the IDF Diabetes Atlas, in 2022, 537 million people in the age group of 20-79 were diagnosed with diabetes globally. The same source further predicted that by 2030, the prevalence of diabetes is expected to rise to 643 million. Hyperglycemia is linked with the development of diabetic kidney disease which in itself plays as a key risk factor for chronic kidney disease and end stage renal disease. It has been established in numerous research high blood sugar levels affect the kidneys in multifactorial ways. For instance, high blood sugar result in the narrowing of blood vessels supplying the kidney which significantly impacts the filtration capacities of the kidneys. High glycemic levels are associated with chronic hemodynamic and metabolic changes which in turn, are associated with changes in the signaling pathways, cytokines, transcription factors, and other factors. Therefore, the rising prevalence of diabetes is linked with the increasing number of cases associated with kidney diseases such as diabetic kidney disease and end stage renal disease thereby driving the demand for dialysis procedures and ultimately positively influencing the dialysis devices market during the forecast period (2024-2030).

Another important aspect driving the demand for dialysis devices market is the ascent in the geriatric population base. As per the figures cited by the World Health Organization in their Decade of Healthy Ageing (2020-2030) Report, it is estimated that people over the age of 60 years and older will account for 34% more share in the total population, from one billion in 2019 to accounting for 1.4 billion by 2030. The report further states that by 2050, the world's elderly population is expected to reach 2.1 billion. Aging is associated with progressive decline of kidney function as senescence-related structural, molecular, and functional changes affect the reparative capacity of kidney thereby predisposing older people to various renal diseases. Therefore, the growing elderly population is predicted to result in increase in incidence of renal diseases resulting in growing demand for dialysis thereby bolstering the growth of the dialysis devices market in coming years.

However, procedure-related complications and the high cost of dialysis services for patients in growing economies may be growth-restraining factors for the dialysis devices market.

Besides the above-mentioned factors, the dialysis devices market witnessed a slight dip in revenue generation due to the COVID-19 pandemic. Even though due to the urgent nature of dialysis services in terms of supporting life, there was a slight dip in conductance of such procedures however the trends across the globe varied massively. For this specific market, restrictions pertaining to the COVID-19 pandemic did not affect the demand for dialysis as such due to the life supporting nature of the therapy. However, the post-pandemic scenario provides an even opportune moment for revenue generation for the dialysis devices market due to the resumption of activities in full capacity thereby improving the market outlook for the dialysis devices market during the forecast period.

Dialysis Devices Market Segment Analysis:

Dialysis Devices Market by Product Type (Hemodialysis Machines, Peritoneal Dialysis Machines, Continuous Renal Replacement Therapy Machines and Consumables), by Mobility (Stationary and Portable), by End User (Hospitals, Dialysis Centers, and Homecare Settings), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the dialysis devices market, the continuous renal replacement therapy (CRRT) category is expected to register the fastest CAGR in the dialysis devices market during the forecast period. This can be attributed to the advantages offered by this type of dialysis. One of the key advantages associated with CRRT is that it is a slower type of dialysis which remarkably decreases the load on the heart during dialysis compared to other dialysis procedures. It is conducted over the period of 24 hours instead of doing it over four hours, which ultimately decreases the stress on the heart.

Additionally, compared to intermittent hemodialysis, CRRT is preferred in patients suffering from sepsis-induced acute kidney injury in removing various components such as excess metabolic waste and water, also helps in lowering pro-inflammatory cytokine levels, helps in maintaining homeostasis, lowers the negative impact on the cardiovascular system, thereby significantly improving the prognosis of the patient. Furthermore, as it has been established in various recent studies, CRRT is being preferred in COVID-19 patients with acute kidney injury as it was observed that besides helping in overcoming limitations of kidney function, it helped in ceasing the progression of severe COVID-19 infection as the CRRT therapy could remove the pro-inflammatory cytokines during the cytokine storm syndrome reported in severe COVID-19 infection.

Therefore, the demand for dialysis devices, specifically CRRT is set to register remarkable growth during the forecast period, ultimately helping the dialysis market to generate commendable revenue.

North America is expected to dominate the overall Dialysis Devices Market:

Among all the regions, North America is estimated to account for the largest share in the dialysis devices market. This domination is due to the rising prevalence of kidney disorders, rising population of patients suffering from lifestyle disorders such as obesity and hypertension. Moreover, extensive efforts in product developmental activities and growing popularity of home-based dialysis devices are further expected to drive the product demand in the North American region. In addition to the above-stated factors, the new product launches and approvals and the extensive coverage of procedural cost specifically in the United States and Canada are expected to further boost the market for dialysis devices in North America.

One of the key driving factors of the United States dialysis devices market is the interplay of various factors in the country. For instance, as per the data cited by the Centers for Disease Control and Prevention (2023), about 15% of the adults in the United States (accounting for approximately 37 million people) are estimated to have chronic kidney disease. According to further estimates presented by the source, women are slightly more affected by CKD as compared to men. CKD, over time, progresses to kidney failure thereby necessitating the need for dialysis. Therefore, the growing burden of kidney disorders indicated by the increase in patient population corresponds to the presence of a potential patient population that may require dialysis as a life supporting therapy, thus positively influencing the product demand in the nation.

Additionally, another key factor that is thought to contribute to the increasing prevalence of kidney disorders is the surge in obesity in the country population. For instance, as per the data provided by the CDC (2023), in 2017-2018, the obesity prevalence in the country was 42.4%. Obesity has been established as a formidable risk factor for the development of kidney disease. It has been studied that in patients affected by obesity, a compensatory mechanism of hyper filtration is said to take place to meet the increased metabolic demands due to gain in body weight. This can massively increase the intraglomerular pressure which may damage the kidney structure and escalate the risk of developing CKD in the long term.

Furthermore, the product development activities and product approvals by the concerned regulatory authority in North American countries are further expected to drive the product demand in the region. For instance, in March 2022, Baxter Healthcare Corporation received the regulatory approval from the US Food and Drug Administration for their AK 98 Dialysis Machine, classified as a class II medical device.

Moreover, the conducive health coverage scenario specifically in the United States and Canada also provides conditions for the regional market to grow as the coverage of procedural cost of dialysis by public and private insurers help in more people availing such services thereby contributing in the increase in access to dialysis services in the region.

Thus, the interplay of all the previously factors are likely to contribute to the market growth of dialysis devices in the United States as well as North America region as a whole during the forecast period.

Dialysis Devices Market Key Players:

Some of the key market players operating in the dialysis devices market includes Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co.,Ltd, TORAY MEDICAL CO,.LTD., Trivitron Healthcare, BLT Biolight Meditech, QUANTA Dialysis Technologies, and others.

Recent Developmental Activities in Dialysis Devices Market:

In January 2022, the US Food and Drug Administration granted the regulatory approval to Quanta Dialysis Technologies Ltd for their product- hemodialysis system SC+. The device is a portable system which is capable of offering dialysis care comparable to full-sized dialysis equipment in a range of care settings.

In August 2020, the US FDA granted the emergency-use authorization (EUA) for REGIOCIT which is intended to be used as a replacement solution specifically in adult patients who are being treated with CRRT and for whom regional citrate anticoagulation is considered appropriate.

In October 2018, Baxter received the CE mark approval for the next-generation continuous renal replacement therapy using PrisMax system.

Key Takeaways from the Dialysis Devices Market Report Study

Market size analysis for current dialysis devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the dialysis devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the global dialysis devices market.

Various opportunities available for the other competitor in the dialysis devices market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current dialysis devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for dialysis devices market growth in the coming future?

Target Audience who can be benefited from this Dialysis Devices Market Report Study

Dialysis devices products providers

Research organizations and consulting companies

Dialysis devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in dialysis devices

Various End-users who want to know more about the dialysis devices market and latest technological developments in the dialysis devices market.

Frequently Asked Questions for Dialysis Devices Market:

1. What is a dialysis device?

Dialysis devices are medical equipment and consumables that help in substituting for kidney function in events of kidney failure or compromised kidney function to compensate and remove toxins from the body.

2. What is the market for Global Dialysis Devices?

Global dialysis devices market was valued at USD 74.44 billion in 2023, growing at a CAGR of 4.84% during the forecast period from 2024 to 2030 to reach USD 98.84 billion by 2030.

3. What are the drivers for Global Dialysis Devices Market?

The demand for dialysis devices is witnessing a surge majorly due to the rising prevalence of kidney failure due to various reasons such as rising geriatric population wherein age acts as a major risk factor for loss of kidney function, rising prevalence of diabetes in which hyperglycemia is linked with blood vessel damage in kidneys. Furthermore, hypertension is another key factor which is extensively linked with kidney failure. Additionally, the technological advancements such as the development of continuous renal replacement therapy (CRRT) have also been a major influential factor in boosting the growth of the dialysis devices market during the forecast period from 2024-2030.

4. Who are the key players operating in Global Dialysis Devices Market?

Some of the key market players operating in the dialysis devices market includes Fresenius Medical Care, B. Braun Melsungen AG, Nipro Corporation, Dialife SA, Baxter, Cantel Medical Corporation, NIKKISO CO., LTD, Asahi Kasei Medical, NxStage Medical, Inc. Infomed SA, Medtronic, Anjue Medical Equipment Co., Ltd., Dialco Medical Inc., SWS Hemodialysis Care Co.,Ltd, TORAY MEDICAL CO,.LTD., Trivitron Healthcare, BLT Biolight Meditech, QUANTA Dialysis Technologies, and others.

5. Which region has the highest share in Dialysis Devices market?

Among all the regions, North America is estimated to account for the largest share in the dialysis devices market. This domination is due to the rising prevalence of kidney disorders, rising population of patients suffering from lifestyle disorders such as obesity and hypertension. Moreover, extensive efforts in product developmental activities and growing popularity of home-based dialysis devices are further expected to drive the product demand in the North American region. In addition to the above-stated factors, the new product launches and approvals and the extensive coverage of procedural cost specifically in the United States and Canada are expected to further boost the market for dialysis devices in North America.

Table of Contents

1.Dialysis Devices Market Report Introduction

2.Dialysis Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Dialysis Devices Market Key Factors Analysis

  • 4.1. Dialysis Devices Market Drivers
    • 4.1.1. Growing Geriatric Population Base
    • 4.1.2. Increasing Prevalence of Diabetes
    • 4.1.3. Rising Prevalence of Hypertension
    • 4.1.4. Technological Advancements in Product Development
  • 4.2. Dialysis Devices Market Restraints and Challenges
    • 4.2.1. Procedure-Related Complications
    • 4.2.2. High Cost of Dialysis Services for Patients in Growing Economies
  • 4.3. Dialysis Devices Market Opportunities
    • 4.3.1. Improving on the Product Design
    • 4.3.2. Improving Access of Dialysis Services in Emerging Economies

5. Dialysis Devices Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Dialysis Devices Market

7. Dialysis Devices Market Layout

  • 7.1. By Product Type
    • 7.1.1. Hemodialysis Machines
    • 7.1.2. Peritoneal Dialysis Machines
    • 7.1.3. Continuous Renal Replacement Therapy Machines
    • 7.1.4. Consumables
  • 7.2. By Mobility
    • 7.2.1. Stationary
    • 7.2.2. Portable
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Dialysis Centers
    • 7.3.3. Homecare Settings
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Dialysis Devices Market, by Product Type
      • 7.4.1.2. North America Dialysis Devices Market, by Mobility
      • 7.4.1.3. North America Dialysis Devices Market, by End User
      • 7.4.1.4. North America Dialysis Devices Market, by Country
      • 7.4.1.4.1. United States
      • 7.4.1.4.2. Canada
      • 7.4.1.4.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Dialysis Devices Market, by Product Type
      • 7.4.2.2. Europe Dialysis Devices Market, by Mobility
      • 7.4.2.3. Europe Dialysis Devices Market, by End User
      • 7.4.2.4. Europe Dialysis Devices Market, by Country
      • 7.4.2.4.1. France
      • 7.4.2.4.2. Germany
      • 7.4.2.4.3. United Kingdom
      • 7.4.2.4.4. Italy
      • 7.4.2.4.5. Spain
      • 7.4.2.2.6. Russia
      • 7.4.2.2.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Dialysis Devices Market, by Product Type
      • 7.4.3.2. Asia-Pacific Dialysis Devices Market, by Mobility
      • 7.4.3.3. Asia-Pacific Dialysis Devices Market, by End User
      • 7.4.3.4. Asia-Pacific Dialysis Devices Market, by Country
      • 7.4.3.4.1. China
      • 7.4.3.4.2. Japan
      • 7.4.3.4.3. India
      • 7.4.3.4.4. Australia
      • 7.4.3.4.5. South Korea
      • 7.4.3.4.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Dialysis Devices Market, by Product Type
      • 7.4.4.2. RoW Dialysis Devices Market, by Mobility
      • 7.4.4.3. RoW Dialysis Devices Market, by End User
      • 7.4.4.4. RoW Dialysis Devices Market, by Region
      • 7.4.4.4.1. Middle East
      • 7.4.4.4.2. Africa
      • 7.4.4.4.3. South America

8. Dialysis Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Dialysis Devices Market Company and Product Profiles

  • 9.1. Fresenius Medical Care,
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. B. Braun Melsungen AG
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Nipro Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Dialife SA
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Baxter
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Cantel Medical Corporation
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. NIKKISO CO. LTD.
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Asahi Kasei Medical
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. NxStage Medical, Inc
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Infomed SA
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Medtronic
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Anjue Medical Equipment Co., Ltd
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Dialco Medical Inc
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. SWS Hemodialysis Care Co.,Ltd
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. TORAY MEDICAL CO,.LTD
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy
  • 9.16. Trivitron Healthcare
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4. Product Listing
    • 9.16.5. Entropy
  • 9.17. BLT Biolight Meditech
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4. Product Listing
    • 9.17.5. Entropy
  • 9.18. QUANTA Dialysis Technologies
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4. Product Listing
    • 9.18.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis on Dialysis Devices Market
  • Table 3: Dialysis Devices Market in Global (2021-2030)
  • Table 4: Dialysis Devices Market in Global by Product Type (2021-2030)
  • Table 5: Dialysis Devices Market in Global by Mobility (2021-2030)
  • Table 6: Dialysis Devices Market in Global by End User (2021-2030)
  • Table 7: Dialysis Devices Market in Global by Geography (2021-2030)
  • Table 8: Dialysis Devices Market in North America (2021-2030)
  • Table 9: Dialysis Devices Market in North America by Product Type (2021-2030)
  • Table 10: Dialysis Devices Market in North America by Mobility (2021-2030)
  • Table 11: Dialysis Devices Market in North America by End User (2021-2030)
  • Table 12: Dialysis Devices Market in North America by Country (2021-2030)
  • Table 13: Dialysis Devices Market in the US (2021-2030)
  • Table 14: Dialysis Devices Market in Canada (2021-2030)
  • Table 15: Dialysis Devices Market in Mexico (2021-2030)
  • Table 16: Dialysis Devices Market in Europe (2021-2030)
  • Table 17: Dialysis Devices Market in Europe by Product Type (2021-2030)
  • Table 18: Dialysis Devices Market in Europe by Mobility (2021-2030)
  • Table 19: Dialysis Devices Market in Europe by End User (2021-2030)
  • Table 20: Dialysis Devices Market in Europe by Country (2021-2030)
  • Table 21: Dialysis Devices Market in France (2021-2030)
  • Table 22: Dialysis Devices Market in Germany (2021-2030)
  • Table 23: Dialysis Devices Market in the United Kingdom (2021-2030)
  • Table 24: Dialysis Devices Market in Italy (2021-2030)
  • Table 25: Dialysis Devices Market in Spain (2021-2030)
  • Table 26: Dialysis Devices Market in Russia (2021-2030)
  • Table 27: Dialysis Devices Market in Rest of Europe (2021-2030)
  • Table 28: Dialysis Devices Market in APAC (2021-2030)
  • Table 29: Dialysis Devices Market in APAC by Product Type (2021-2030)
  • Table 30: Dialysis Devices Market in APAC by Mobility (2021-2030)
  • Table 31: Dialysis Devices Market in APAC by End User (2021-2030)
  • Table 32: Dialysis Devices Market in APAC by Country (2021-2030)
  • Table 33: Dialysis Devices Market in China (2021-2030)
  • Table 34: Dialysis Devices Market in Japan (2021-2030)
  • Table 35: Dialysis Devices Market in India (2021-2030)
  • Table 36: Dialysis Devices Market in Australia (2021-2030)
  • Table 37: Dialysis Devices Market in South Korea (2021-2030)
  • Table 38: Dialysis Devices Market in Rest of APAC (2021-2030)
  • Table 39: Dialysis Devices Market in Rest of World (2021-2030)
  • Table 40: Dialysis Devices Market in RoW by Product Type (2021-2030)
  • Table 41: Dialysis Devices Market in RoW by Mobility (2021-2030)
  • Table 42: Dialysis Devices Market in RoW by End User (2021-2030)
  • Table 43: Dialysis Devices Market in RoW by Region (2021-2030)
  • Table 44: Dialysis Devices Market in Middle East (2021-2030)
  • Table 45: Dialysis Devices Market in Africa (2021-2030)
  • Table 46: Dialysis Devices Market in South America (2021-2030)

List of Figures

Figures 1: Competitive Analysis

Figures 2: COVID-19 Impact Analysis on Dialysis Devices Market

Figures 3: Dialysis Devices Market in Global (2021-2030)

Figures 4: Dialysis Devices Market in Global by Product Type (2021-2030)

Figures 5: Dialysis Devices Market in Global by Mobility (2021-2030)

Figures 6: Dialysis Devices Market in Global by End User (2021-2030)

Figures 7: Dialysis Devices Market in Global by Geography (2021-2030)

Figures 8: Dialysis Devices Market in North America (2021-2030)

Figures 9: Dialysis Devices Market in North America by Product Type (2021-2030)

Figures 10: Dialysis Devices Market in North America by Mobility (2021-2030)

Figures 11: Dialysis Devices Market in North America by End User (2021-2030)

Figures 12: Dialysis Devices Market in North America by Country (2021-2030)

Figures 13: Dialysis Devices Market in the US (2021-2030)

Figures 14: Dialysis Devices Market in Canada (2021-2030)

Figures 15: Dialysis Devices Market in Mexico (2021-2030)

Figures 16: Dialysis Devices Market in Europe (2021-2030)

Figures 17: Dialysis Devices Market in Europe by Product Type (2021-2030)

Figures 18: Dialysis Devices Market in Europe by Mobility (2021-2030)

Figures 19: Dialysis Devices Market in Europe by End User (2021-2030)

Figures 20: Dialysis Devices Market in Europe by Country (2021-2030)

Figures 21: Dialysis Devices Market in France (2021-2030)

Figures 22: Dialysis Devices Market in Germany (2021-2030)

Figures 23: Dialysis Devices Market in the United Kingdom (2021-2030)

Figures 24: Dialysis Devices Market in Italy (2021-2030)

Figures 25: Dialysis Devices Market in Spain (2021-2030)

Figures 26: Dialysis Devices Market in Russia (2021-2030)

Figures 27: Dialysis Devices Market in Rest of Europe (2021-2030)

Figures 28: Dialysis Devices Market in APAC (2021-2030)

Figures 29: Dialysis Devices Market in APAC by Product Type (2021-2030)

Figures 30: Dialysis Devices Market in APAC by Mobility (2021-2030)

Figures 31: Dialysis Devices Market in APAC by End User (2021-2030)

Figures 32: Dialysis Devices Market in APAC by Country (2021-2030)

Figures 33: Dialysis Devices Market in China (2021-2030)

Figures 34: Dialysis Devices Market in Japan (2021-2030)

Figures 35: Dialysis Devices Market in India (2021-2030)

Figures 36: Dialysis Devices Market in Australia (2021-2030)

Figures 37: Dialysis Devices Market in South Korea (2021-2030)

Figures 38: Dialysis Devices Market in Rest of APAC (2021-2030)

Figures 39: Dialysis Devices Market in Rest of World (2021-2030)

Figures 40: Dialysis Devices Market in RoW by Product Type (2021-2030)

Figures 41: Dialysis Devices Market in RoW by Mobility (2021-2030)

Figures 42: Dialysis Devices Market in RoW by End User (2021-2030)

Figures 43: Dialysis Devices Market in RoW by Region (2021-2030)

Figures 44: Dialysis Devices Market in Middle East (2021-2030)

Figures 45: Dialysis Devices Market in Africa (2021-2030)

Figures 46: Dialysis Devices Market in South America (2021-2030)

Figures 47: Market Drivers

Figures 48: Market Barriers

Figures 49: Marker Opportunities

Figures 50: PORTER'S Five Force Analysis